- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06171698
Impedance During Cardiac Catheterization to Build a Non-Invasive Cardiac Output Algorithm
July 9, 2025 updated by: Johns Hopkins University
Prospective Measurement of Impedance During Cardiac Catheterization to Build a Non-Invasive Cardiac Output Algorithm
Prospectively measure impedance during cardiac catheterization to build a cardiac output algorithm.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Children's Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Scheduled to undergo cardiac catheterization with cardiac output measurement and Fick
- Planned to undergo general anesthesia for cardiac catheterization standard of care
- Parent/Guardian able to provide informed consent
Exclusion Criteria:
- Not planned for standard of care general anesthesia for cardiac catheterization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Research Prototype Monitor
|
Continuous vital sign is collected via a research prototype monitor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of a non-invasive monitoring device
Time Frame: From device placement to removal, up to 12 hours
|
Feasibility of a non-invasive monitoring device that can accurately measure cardiac output in patients with congenital heart disease as determined by percent error compared to catheter-measured cardiac output.
|
From device placement to removal, up to 12 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Danielle Gottlieb Sen, MD, MPH, Johns Hopkins School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2023
Primary Completion (Actual)
June 24, 2025
Study Completion (Actual)
June 24, 2025
Study Registration Dates
First Submitted
November 28, 2023
First Submitted That Met QC Criteria
December 13, 2023
First Posted (Actual)
December 15, 2023
Study Record Updates
Last Update Posted (Actual)
July 14, 2025
Last Update Submitted That Met QC Criteria
July 9, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00281586
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingAdult Congenital Heart Disease | Congenital Heart Disease (CHD) | Pediatric Congenital Heart Disease | Heart Transplant PatientsItaly
-
Seoul National University HospitalUniversity of SeoulNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD) | Complex Congenital Heart DiseaseKorea, Republic of
-
University of UlsterBelfast Health and Social Care TrustCompletedCongenital Heart Disease | Congenital Heart Defect | Adult Congenital Heart DiseaseUnited Kingdom
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
China National Center for Cardiovascular DiseasesPeking University; Shandong University; Guangxi Medical University; Wenzhou Medical... and other collaboratorsActive, not recruitingStructural Heart Disease | Congenital Heart Disease (CHD)China
-
Children's Hospital Medical Center, CincinnatiNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Disease CongenitalUnited States
-
Martin SchweigerUniversity Children's Hospital, ZurichRecruitingFontan Physiology | Congenital Heart Disease in Children | Congenital Heart SurgerySwitzerland
-
University Hospital, BordeauxNot yet recruitingCHD - Congenital Heart DiseaseFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingAdult Congenital Heart DiseaseItaly
-
University of CalgaryThe Hospital for Sick Children; Alberta Children's HospitalNot yet recruitingCongenital Heart Disease (CHD)
Clinical Trials on Research Prototype Monitor
-
Mayo ClinicCompletedGastroesophageal Reflux | GERDUnited States
-
University of Maryland, BaltimoreDexCom, Inc.Not yet recruiting
-
Cryonove PharmaCEISO; DermatechCompletedPost-inflammatory HyperpigmentationSouth Africa
-
Sheffield Children's NHS Foundation TrustSheffield Hallam UniversityActive, not recruiting
-
Sheffield Children's NHS Foundation TrustCompletedRheumatologic DiseaseUnited Kingdom
-
EchosensCompletedObesity, Morbid | Liver FibrosisFrance
-
Shiphrah Biomedical Inc.University of South AustraliaTerminatedPregnancy Complications | Fetal Growth Retardation | Sleep-Disordered Breathing | Infant, Very Low Birth Weight | Stillbirth | Infant, Small for Gestational Age | Fetal Hypoxia | Infant, Low Birth WeightAustralia
-
Cryonove PharmaCEISO; Dermatech; INNOVSOLUTIONCompleted
-
Kenvue Brands LLCCompleted
-
Philips Electronics Nederland B.V. acting through...Leiden University Medical CenterTerminated